Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,370 | 7 | 82.2% |
| Education | $296.75 | 4 | 17.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DENTSPLY Canada Ltd | $978.22 | 3 | $0 (2024) |
| Biogen, Inc. | $249.29 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $220.75 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $121.05 | 1 | $0 (2023) |
| Genentech USA, Inc. | $76.00 | 2 | $0 (2017) |
| Incyte Corporation | $21.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $999.42 | 4 | DENTSPLY Canada Ltd ($978.22) |
| 2023 | $121.05 | 1 | Alexion Pharmaceuticals, Inc. ($121.05) |
| 2019 | $110.50 | 1 | Teva Pharmaceuticals USA, Inc. ($110.50) |
| 2018 | $359.54 | 3 | Biogen, Inc. ($249.29) |
| 2017 | $76.00 | 2 | Genentech USA, Inc. ($76.00) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/03/2024 | DENTSPLY Canada Ltd | MIS (Device) | Food and Beverage | In-kind items and services | $333.91 | General |
| Category: Implant Dentistry | ||||||
| 09/03/2024 | DENTSPLY Canada Ltd | MIS (Device) | Food and Beverage | In-kind items and services | $314.84 | General |
| Category: Implant Dentistry | ||||||
| 08/22/2024 | DENTSPLY Canada Ltd | MIS (Device) | Food and Beverage | In-kind items and services | $329.47 | General |
| Category: Implant Dentistry | ||||||
| 05/09/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: Hematology/Oncology | ||||||
| 02/16/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $121.05 | General |
| Category: Rare Disease | ||||||
| 09/10/2019 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $110.50 | General |
| 10/18/2018 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $124.29 | General |
| Category: NEUROLOGY | ||||||
| 05/17/2018 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $110.25 | General |
| 02/20/2018 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 08/10/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 08/10/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 28 | $7,500 | $2,961 |
| 2022 | 1 | 18 | 18 | $8,100 | $2,281 |
| 2021 | 1 | 12 | 14 | $2,100 | $1,348 |
| 2020 | 1 | 12 | 15 | $2,250 | $909.09 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $2,550 | $1,547 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,950 | $1,413 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $8,100 | $2,281 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $2,100 | $1,348 | 64.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 15 | $2,250 | $909.09 | 40.4% |
About Dr. I. Levin, M.D
Dr. I. Levin, M.D is a Neurology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518911478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. I. Levin, M.D has received a total of $1,667 in payments from pharmaceutical and medical device companies, with $999.42 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,370).
As a Medicare-enrolled provider, Levin has provided services to 67 Medicare beneficiaries, totaling 75 services with total Medicare billing of $7,499. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Philadelphia, PA
- Active Since 05/22/2006
- Last Updated 07/01/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1518911478
Products in Payments
- MIS (Device) $978.22
- TECFIDERA (Drug) $249.29
- SOLIRIS (Biological) $121.05
- OCREVUS (Biological) $76.00
- JAKAFI (Drug) $21.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Philadelphia
Dr. Thomas Leist, M.d, M.D
Neurology — Payments: $2.0M
Dr. Daniel Kremens, M.d., J.d, M.D., J.D
Neurology — Payments: $1.9M
Dr. Jill Giordano Farmer, Do, DO
Neurology — Payments: $1.1M
Dr. Stephen Silberstein, M.d, M.D
Neurology — Payments: $936,801
Amit Bar-Or
Neurology — Payments: $904,147
Dr. Stephanie Nahas-Geiger, M.d, M.D
Neurology — Payments: $828,295